Has Abby Skripko received payments from drug or device companies?

Yes. Drug and device makers reported $4,379 in general payments to Abby Skripko across 184 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Abby Skripko did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Abby Skripko come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Abby Skripko

Medical · Lebanon, PANPI 1164836144

Payments from drug & device makers

$4,379in general payments, 2019–2025

Across 184 payments — averaging $23.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

E.r. Squibb & Sons, L.L.C.$624
AstraZeneca$471
Incyte Corporation$355
Seagen Inc.$300
Novartis$249
Johnson & Johnson$217
plus $2K from 28 others

What the payments were for

Food & beverage$3,88989%
Education$49011%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
E.r. Squibb & Sons, L.L.C.	21	$624
AstraZeneca(2 entities)	20	$471
Incyte Corporation	14	$355
Seagen Inc.	12	$300
Novartis	16	$249
Johnson & Johnson(2 entities)	4	$217
Sanofi	8	$183
Amgen	5	$177
Bristol Myers Squibb	8	$171
Pfizer	8	$162
Sobi, Inc	3	$142
Merck	9	$127
Pharmacyclics LLC, An Abbvie Company	6	$112
Daiichi Sankyo Inc.	5	$111
Sanofi-aventis U.S. LLC	1	$100
Genentech USA, Inc.	5	$100
EMD Serono, Inc.	4	$85
Jazz Pharmaceuticals Inc.	3	$77
Lilly USA, LLC	4	$70
Foundation Medicine, Inc.	2	$63
Ipsen Biopharmaceuticals, Inc	3	$61
Taiho Oncology, Inc.	3	$57
Regeneron Healthcare Solutions, Inc.	2	$54
Bayer	2	$44
Karyopharm Therapeutics Inc.	2	$37
Morphosys, US Inc.	2	$35
Rigel Pharmaceuticals, Inc.	2	$35
Gilead	2	$34
AMAG Pharmaceuticals, Inc.	2	$32
Eisai Inc.	2	$32
Beigene USA, Inc.	1	$20
Agios Pharmaceuticals, Inc.	1	$16
Dova Pharmaceuticals	1	$14
Astellas Pharma US Inc	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,379 in reported general payments places this provider in the 85th percentile of 2,594 medical providers in Pennsylvania.

See all medical providers in Pennsylvania →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Tamoxifen Citrate	16	$572
Anastrozole	14	$562

Paid to pharmacies, not to this prescriber.

Other medical in Lebanon

Jacqueline KernaghanSpringfield$427K
Drew SodaNew Hope$220K
Angela KapalkoPhiladelphia$123K
Linda PerryPhiladelphia$123K
Cory DavidsonErie$119K
Shelley SassamanTamaqua$90K
Meghan HoffnerBethlehem$86K
Thomas IacovoniDanville$72K
Scott CoxWynnewood$66K
Sarah SmithPhiladelphia$65K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →